SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Feb 11, 2019

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Feb. 11, 2019 · CIK: 0001711786 · Accession: 0001615774-19-002257

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-227772

Date

Feb. 11, 2019

Author

Title: Chief

Form

CORRESP

Company

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

Rockefeller Plaza, Suite 1039

New York, New York 10020

February 11, 2019

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Effie Simpson

Doug Jones

Julie Griffith

Susan Block

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-1, as amended

File No. 333-227772

Ladies and Gentlemen:

Reference is made to the Hoth Therapeutics, Inc.’s (the “Company’s”) request for acceleration filed as correspondence via EDGAR on February 6, 2019. The Company is no longer requesting that the Registration Statement be declared effective at this time and the Company hereby formally withdraws it request for acceleration of the effective date.

Should you have any questions regarding the foregoing, please do not hesitate to contact our counsel, Richard Friedman, Esq. of Sheppard Mullin Richter & Hampton LLP, at (212) 634-3031.

Thank you,

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

Hoth
Therapeutics, Inc.

1
Rockefeller Plaza, Suite 1039

New
York, New York 10020

February
11, 2019

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

 Attention:  Effie
Simpson

Doug Jones

Julie Griffith

Susan
Block

 Re: Hoth
Therapeutics, Inc.

Registration Statement on Form S-1, as amended

File
No. 333-227772

Ladies
and Gentlemen:

 Reference
is made to the Hoth Therapeutics, Inc.’s (the “Company’s”) request for acceleration filed as correspondence via
EDGAR on February 6, 2019. The Company is no longer requesting that the Registration Statement be declared effective at this
time and the Company hereby formally withdraws it request for acceleration of the effective date.

Should
you have any questions regarding the foregoing, please do not hesitate to contact our counsel, Richard Friedman, Esq. of Sheppard
Mullin Richter & Hampton LLP, at (212) 634-3031.

    Thank you,

    HOTH THERAPEUTICS, INC.

    By: /s/
                                         Robb Knie

    Name: Robb
                                         Knie

    Title: Chief
                                         Executive Officer

SecProbe.io